look news india
Iranian media has claimed that Iran's President and Foreign Minister have died in a helicopter crash. Along with this, there is no hope of survival of all the other people aboard the ship. The debris of the helicopter has been found. Now the question is that if the President leaves, who will take his place? At present the name of the Vice President of Iran is at the forefront. Let us tell you that a helicopter carrying Iranian President Ebrahim Raisi, the country's Foreign Minister and other officials crashed in the north-western mountainous area of Iran on Sunday. They have been missing for more than 12 hours. Now it has been confirmed that the President of Iran has died.
Mohammad Mokhbar can become the new President
According to Iranian experts, if Ebrahim Raisi becomes victim of some untoward incident, Vice President Mohammad Mokhbar can become the next President of the country. According to the Constitution of Iran, in the event of the death of the President, the First Vice President will assume the duties of the President. Unless elections are held within a maximum of 50 days. Unlike other countries, the First Vice President of Iran is an appointed position – not elected. After the office of Prime Minister was abolished in 1989, some of the powers of the Prime Minister were transferred to the Vice President.
The post of Mokhbar is important among Vice Presidents.
Iran has several vice presidents and they often serve as cabinet members. But among other Vice Presidents, the post of Mokhbar is considered to be the first important post. Raisi appointed Mokhbar as his first vice president in August 2021, soon after assuming power. He is the seventh person to hold this role since the amendment of the Constitution. Before his appointment to the vice presidency, Mokhbar served for 14 years as the head of Iran's Setad, a powerful economic group that focused mostly on charitable work.
Under Mokhbar's supervision, Setad developed Iran's coronavirus vaccine, Coviran Barakat, at the height of the COVID-19 pandemic. But questions were raised on the effectiveness of the vaccine.